Long Term Tapering or Standard Steroids for Nephrotic Syndrome
Sponsor: Institute of Child Health
Listed as NCT00308321, this PHASE4 trial focuses on Nephrotic Syndrome and remains ongoing. Sponsored by Institute of Child Health, it has been updated 5 times since 2003, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE4
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE4
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status PHASE4
-
Jan 2017 — Jun 2018 [monthly]
Unknown Status PHASE4
First recorded
Sep 2003
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Institute of Child Health
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • London, United Kingdom